Comparison of Low-Value Services Among Medicare Advantage and Traditional Medicare Beneficiaries.


Journal

JAMA health forum
ISSN: 2689-0186
Titre abrégé: JAMA Health Forum
Pays: United States
ID NLM: 101769500

Informations de publication

Date de publication:
02 09 2022
Historique:
entrez: 11 10 2022
pubmed: 12 10 2022
medline: 14 10 2022
Statut: epublish

Résumé

Low-value care in the Medicare program is prevalent, costly, potentially harmful, and persistent. Although Medicare Advantage (MA) plans can use managed care strategies not available in traditional Medicare (TM), it is not clear whether this flexibility is associated with lower rates of low-value care. To compare rates of low-value services between MA and TM beneficiaries and explore how elements of insurance design present in MA are associated with the delivery of low-value care. This cross-sectional study analyzed beneficiaries enrolled in MA and TM using claims data from a large, national MA insurer and a random 5% sample of TM beneficiaries. The study period was January 1, 2017, through December 31, 2019. All analyses were conducted from July 2021 to March 2022. Enrollment in MA vs TM. Low-value care was assessed using 26 claims-based measures. Regression models were used to estimate the association between MA enrollment and rates of low-value services while controlling for beneficiary characteristics. Stratified analyses explored whether network design, product design, value-based payment, or utilization management moderated differences in low-value care between MA and TM beneficiaries and among MA beneficiaries. Among a study population of 2 470 199 Medicare beneficiaries (mean [SD] age, 75.6 [7.0] years; 1 346 777 [54.5%] female; 229 107 [9.3%] Black and 2 126 353 [86.1%] White individuals), 1 527 763 (61.8%) were enrolled in MA and 942 436 (38.2%) were enrolled in TM. Beneficiaries enrolled in MA received 9.2% (95% CI, 8.5%-9.8%) fewer low-value services in 2019 than TM beneficiaries (23.1 vs 25.4 total low-value services per 100 beneficiaries). Although MA beneficiaries enrolled in health management organization and preferred provider organization products received fewer low-value services than TM beneficiaries, the difference was largest for those enrolled in health management organization products (2.6 fewer [95% CI, 2.4-2.8] vs 2.1 fewer [95% CI, 1.9-2.3] services per 100 beneficiaries, respectively). Across primary care payment arrangements, MA beneficiaries received fewer low-value services than TM beneficiaries, with the largest difference observed for MA beneficiaries whose primary care physicians were reimbursed within 2-sided risk arrangements. In this cross-sectional study of Medicare beneficiaries, those enrolled in MA had lower rates of low-value care than those enrolled in TM; elements of insurance design present in the MA program and absent in TM were associated with reduction in low-value care.

Identifiants

pubmed: 36218933
pii: 2796210
doi: 10.1001/jamahealthforum.2022.2935
pmc: PMC9463603
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e222935

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH112829
Pays : United States

Références

JAMA Netw Open. 2021 Mar 1;4(3):e211762
pubmed: 33729504
Am Econ J Appl Econ. 2019 Apr;11(2):302-332
pubmed: 31131073
Health Aff (Millwood). 2017 Jun 1;36(6):1065-1069
pubmed: 28583965
JAMA Intern Med. 2019 Jan 1;179(1):16-25
pubmed: 30508010
J Gen Intern Med. 2015 Feb;30(2):221-8
pubmed: 25373832
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
JAMA Intern Med. 2015 Nov;175(11):1815-25
pubmed: 26390323
Health Aff (Millwood). 2022 Jan;41(1):120-128
pubmed: 34982629
JAMA. 2019 Oct 15;322(15):1501-1509
pubmed: 31589283
JAMA Intern Med. 2014 Jul;174(7):1067-76
pubmed: 24819824
JAMA Netw Open. 2021 Feb 1;4(2):e2037328
pubmed: 33591365
Med Care Res Rev. 2017 Oct;74(5):507-550
pubmed: 27402662
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
JAMA Health Forum. 2021 May 28;2(5):e210859
pubmed: 35977311
Med Care. 2017 Nov;55(11):931-939
pubmed: 28930892
JAMA Intern Med. 2016 Jul 1;176(7):998-1004
pubmed: 27244044

Auteurs

Emily Boudreau (E)

Humana Inc, Louisville, Kentucky.

Richard Schwartz (R)

Humana Inc, Louisville, Kentucky.

Aaron L Schwartz (AL)

Department of Medical Ethics and Health Policy, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Crescenz VA Medical Center, Philadelphia, Pennsylvania.

Amol S Navathe (AS)

Department of Medical Ethics and Health Policy, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Crescenz VA Medical Center, Philadelphia, Pennsylvania.

Ariel Caplan (A)

Humana Inc, Louisville, Kentucky.

Yong Li (Y)

Humana Inc, Louisville, Kentucky.

Andy Blink (A)

Humana Inc, Louisville, Kentucky.

Patrick Racsa (P)

Humana Inc, Louisville, Kentucky.

Dana Drzayich Antol (DD)

Humana Inc, Louisville, Kentucky.

C Jo Erwin (CJ)

Humana Inc, Louisville, Kentucky.

William H Shrank (WH)

Humana Inc, Louisville, Kentucky.

Brian W Powers (BW)

Humana Inc, Louisville, Kentucky.
Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH